SRTA: blade.com Growth-Adjusted Market Cap to Net Income
The upward P/E multiple trend demonstrates the resilience of Strata Critical Medical (SRTA), whose position is strengthened by clinic confidence in high-precision equipment. Revenues are based on emergency aviation transport of organs for hospital networks. The stability of operations is ensured by the hiring of experienced pilots and dispatchers. Meanwhile, the 0.00 mark serves as a current indicator, allowing for an assessment of the business's fair value without market noise.
Strata Critical Medical Inc (SRTA) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio Strata Critical Medical Inc|SRTA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital blade.com|SRTA - Company Debts|Debt to Book Value Strata Critical Medical Corp|SRTA - Company Long-Term Debts|Short-Term Debt Strata Critical Medical|Immediate Liquidity Ratio blade.com
- earnings and valuation multiples indicators:
SRTA - Net Profit|Company Profit Forecast Strata Critical Medical Inc|SRTA - P/E Multiple|Projected Price to Earnings Strata Medical|SRTA - PEG Multiple|EV/EBITDA Multiple Strata Critical Medical Corp|SRTA - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Strata Critical Medical|SRTA - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months blade.com|SRTA - Earnings growth in current year|Expected net earnings per share growth next year Strata Critical Medical Inc
Fundamental company analysis:SRTA (Blade Air Mobility)
The management competence of Strata Critical Medical (SRTA) in scaling organ logistics makes the PEG ratio a key tool for evaluating the effectiveness of the business expansion. This indicator compares the market value of earnings to their growth rate: a value below one signals that the asset is undervalued relative to its momentum, turning the stock into a potential portfolio driver.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight Corp) - Price/Earnings to Growth Multiple|ClearPoint Neuro - Growth-Adjusted Payback Ratio|STXS (Stereotaxis, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate neurostar.com STIM|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|IVF - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple BBLG|AXNX (Axonics Inc.) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Biolase, Inc. (BIOL)|DYNT (dynatronics.com) - Growth-Adjusted Payback Ratio|PEG Multiple FNA (Paragon 28)|PEG Multiple INVO Bioscience Inc. INVO
